Skip to main content

European Healthcare Acquisition & Growth Company B.V. (EHCS.AS)

Euronext Amsterdam Financial Services Shell CompaniesView data quality →
24.9Poor

ValueMarkers Composite Index

Top 0%#44,700 of 44,707

DCF data not available

Piotroski
3/9
Weak
Beneish
-
Altman
0.58
Distress
DCF Value
-
N/A
ROIC
-5.3%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

European Healthcare Acquisition & Growth Company B.V. (EHCS.AS) — VMCI valuation read

Across 120 indicators, European Healthcare Acquisition & Growth Company B.V. (EHCS.AS) lands at VMCI 25/100. The Financial Services sector median is 50, so the 25-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on EHCS.AS in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, EHCS.AS trades at 21.0x earnings, 17% above the Financial Services median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Financial Services median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of 0.7x leaves covenant headroom for EHCS.AS on the trailing balance sheet.

EHCS.AS fell 3.3% over the trailing 7 days, with a -19.7% read on a 30-day basis.

European Healthcare Acquisition & Growth Company B.V. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more companies or businesses. It also focuses on acquiring companies or businesses in the healthcare sector with a focus on biotechnology and specialty pharma, pharma services, medical technology and medical devices, diagnostic and lab services, and bioinformatics, as well as life science tools subsectors in Europe. The company was incorporated in 2021 and is based in Munich, Germany.

CEO: Thomas RudolphDEwww.ehc-company.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in EHCS.AS’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.